Related Experiment Video

Updated: Aug 7, 2026

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents

Lynne Strasfeld1, David M Weinstock

  • 1Weill Medical College of Cornell University, Department of Medicine, Division of International Medicine and Infectious Diseases, 1300 York Avenue, A-421, New York, NY 10021, USA. lstrasfeld@hotmail.com

Expert Review of Anti-Infective Therapy
|June 15, 2006
PubMed

Insights

New antifungal agents are improving prophylaxis for invasive fungal infections (IFIs) in stem cell transplant patients. These newer options offer better protection against candidiasis and mold infections post-engraftment.

Area of Science:

  • * Hematology
  • * Infectious Diseases
  • * Mycology

Background:

  • * Invasive fungal infections (IFIs), including candidiasis and invasive mold infections, are major causes of morbidity and mortality in hematopoietic stem cell transplant (HSCT) recipients, especially allograft recipients.
  • * Prophylactic strategies are crucial for reducing the burden of IFIs in this immunocompromised population.
  • * Fluconazole was the traditional prophylactic agent, but newer agents are now available.

Purpose of the Study:

  • * To review current challenges in managing IFIs in HSCT recipients.
  • * To discuss the role and efficacy of newer antifungal agents for prophylaxis in allogeneic HSCT.
  • * To highlight advancements in preventing IFIs post-engraftment.

Main Methods:

  • * Review of recent studies and clinical guidelines on antifungal prophylaxis in HSCT.
  • * Analysis of the efficacy of various antifungal agents, including echinocandins and triazoles.
  • * Discussion of prophylactic strategies before and after engraftment.

Main Results:

  • * Echinocandin micafungin approved in 2005 for prophylaxis during neutropenia prior to engraftment.
  • * Mold-active agents (triazoles, echinocandins) are increasingly used for prophylaxis after engraftment in high-risk patients.
  • * Recent studies demonstrate the effectiveness of these newer agents in preventing IFIs.

Conclusions:

  • * Newer antifungal agents have significantly impacted IFI prevention in HSCT recipients.
  • * Mold-active prophylaxis after engraftment is a key strategy for high-risk patients.
  • * Continued research and guideline updates are essential for optimizing IFI prophylaxis.

More Related Videos

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...